News tagged with clinical trials
Related topics: patients , cancer , cancer cells , vaccine , food and drug administration
Adalimumab relieves hidradenitis suppurativa
(HealthDay)—For patients with moderate-to-severe hidradenitis suppurativa (HS), a chronic skin disease characterized by painful abscesses, nodules, and draining fistulas in the axilla and groin, treatment ...
Inflammatory disorders
Dec 18, 2012 |
not rated yet |
0
Sleeping pills owe half their benefits to placebo effect, study finds
Half of the benefit of taking sleeping pills comes from the placebo effect, according to a major new study published in the British Medical Journal.
Medications
Dec 18, 2012 |
5 / 5 (3) |
0
|
First study of new treatment for early stage bipolar disorder
(Medical Xpress)—A North West clinical trial of people who have been diagnosed with bipolar disorder for less than five years will be the first study of its kind to shed light on how new treatments could be more effective ...
Psychology & Psychiatry
Dec 14, 2012 |
1 / 5 (1) |
0
A promising clinical trial to reduce the severity of autistic disorders
Although this therapy is not curative, it nevertheless reduced the autistic disorders' severity in three-quarters of the children. The researchers have filed a request for authorisation to perform a multi-centre European ...
Psychology & Psychiatry
Dec 12, 2012 |
5 / 5 (1) |
0
Older and younger chronic leukemia patients may need different therapy
Doctors should use different therapies when treating older and younger patients with chronic lymphocytic leukemia, according to a new study led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur ...
Cancer
Dec 12, 2012 |
not rated yet |
0
|
Industry sponsorship leads to bias in reported findings of clinical trials
Studies reporting the results of industry sponsored clinical trials present a more favourable picture of the effects of drugs and medical devices than those reporting on non-industry sponsored trials, according to a new Cochrane ...
Other
Dec 11, 2012 |
not rated yet |
1
Experimental agent briefly eases depression rapidly in test: Works in brain like ketamine, with fewer side effects
(Medical Xpress)—A drug that works through the same brain mechanism as the fast-acting antidepressant ketamine briefly improved treatment-resistant patients' depression symptoms in minutes, with minimal untoward side effects, ...
Psychology & Psychiatry
Dec 11, 2012 |
5 / 5 (1) |
0
|
Blood levels of immune protein predict risk in Hodgkin disease
Blood levels of an immunity-related protein, galectin-1, in patients with newly diagnosed Hodgkin lymphoma reflected the extent of their cancer and correlated with other predictors of outcome, scientists reported at the American ...
Cancer
Dec 10, 2012 |
not rated yet |
0
Mobile app boosts weight loss by 15 pounds
Using a mobile app that tracks eating and activity helped people lose an average of 15 pounds and keep it off for at least a year, according to a new Northwestern Medicine study.
Health
Dec 10, 2012 |
3 / 5 (2) |
2
|
To fight incurable metastatic breast cancer, resistance must be broken
One of the most frustrating truths about cancer is that even when a treatment works, it often doesn't work for long because cancer cells find ways to resist. However, researchers reporting studies done in mice in the December ...
Cancer
Dec 10, 2012 |
not rated yet |
0
|
Iron supplements reduce ADHD in low birth weight infants
In a study published today in Pediatrics, scientists at Umeå University in Sweden conclude that giving iron supplements to low birth weight infants reduces the risk of behavior problems like ADHD later in life.
Attention deficit disorders
Dec 10, 2012 |
not rated yet |
0
More than a third of high-risk leukemia patients respond to an experimental new drug
A new drug for patients with acute myeloid leukemia (AML) marked by a specific type of genetic mutation has shown surprising promise in a Phase II clinical trial. In more than a third of participants, the leukemia was completely ...
Medications
Dec 09, 2012 |
not rated yet |
0
Socioeconomic status affects cancer trial referrals
(HealthDay)—Patients of lower socioeconomic status are less likely to be referred to participate in early-phase cancer trials compared with patients of higher socioeconomic status, according to research ...
Cancer
Dec 07, 2012 |
not rated yet |
0
Study: 'ApoE is an ideal target for halting progression of Alzheimer's disease'
Despite researchers' best efforts, no drug exists that can slow, halt or reverse the onslaught of Alzheimer's disease. A progressive and fatal neurodegenerative disorder, Alzheimer's has stolen the memories and livelihoods ...
Alzheimer's disease & dementia
Dec 05, 2012 |
5 / 5 (1) |
0
|
Adult antiviral drug effective in suppressing hepatitis B in teens
A recent clinical trial found that the adult antiviral drug, tenofovir disoproxil fumarate (tenofovir DF), is safe and effective in treating adolescents with hepatitis B virus (HBV). Trial results published in the December ...
Diseases, Conditions, Syndromes
Dec 05, 2012 |
5 / 5 (1) |
0
|
